Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta‐analysis of three large randomized trials

BACKGROUND: Aspirin is of moderate overall benefit for patients with acute disabling ischemic stroke. It is unclear whether functional outcome could be improved after stroke by targeting aspirin to patients with a high risk of recurrent thrombosis or a low risk of haemorrhage. AIMS: We aimed to dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Thompson, Douglas D., Murray, Gordon D., Candelise, Livia, Chen, Zhengming, Sandercock, Peter A. G., Whiteley, William N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973666/
https://www.ncbi.nlm.nih.gov/pubmed/25864571
http://dx.doi.org/10.1111/ijs.12487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973666/
https://www.ncbi.nlm.nih.gov/pubmed/25864571
http://dx.doi.org/10.1111/ijs.12487

Ejemplares similares